BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou T, Li HY, Liao C, Lin W, Lin S. Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus. Stem Cells Int 2020;2020:6518508. [PMID: 32322279 DOI: 10.1155/2020/6518508] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Kamen DL, Wallace C, Li Z, Wyatt M, Paulos C, Wei C, Wang H, Wolf BJ, Nietert PJ, Gilkeson G. Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE. Lupus Sci Med 2022;9:e000704. [PMID: 35820718 DOI: 10.1136/lupus-2022-000704] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Martinez-arroyo O, Ortega A, Forner MJ, Cortes R. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics 2022;14:733. [DOI: 10.3390/pharmaceutics14040733] [Reference Citation Analysis]
3 Venkatadri R, Sabapathy V, Dogan M, Sharma R. Targeting Regulatory T Cells for Therapy of Lupus Nephritis. Front Pharmacol 2021;12:806612. [PMID: 35069220 DOI: 10.3389/fphar.2021.806612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Paganelli A, Trubiani O, Diomede F, Pisciotta A, Paganelli R. Immunomodulating Profile of Dental Mesenchymal Stromal Cells: A Comprehensive Overview. Front Oral Health 2021;2:635055. [PMID: 35047993 DOI: 10.3389/froh.2021.635055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kuca-warnawin E, Olesińska M, Szczȩsny P, Kontny E. Impact and Possible Mechanism(s) of Adipose Tissue-Derived Mesenchymal Stem Cells on T-Cell Proliferation in Patients With Rheumatic Disease. Front Physiol 2022;12:749481. [DOI: 10.3389/fphys.2021.749481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Abreu H, Canciani E, Raineri D, Cappellano G, Rimondini L, Chiocchetti A. Extracellular Vesicles in Musculoskeletal Regeneration: Modulating the Therapy of the Future. Cells 2021;11:43. [PMID: 35011605 DOI: 10.3390/cells11010043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scand J Immunol 2021;:e13131. [PMID: 34936112 DOI: 10.1111/sji.13131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Filidou E, Kandilogiannakis L, Tarapatzi G, Su C, Po ENF, Paspaliaris V, Kolios G. Conditioned medium from a human adipose-derived stem cell line ameliorates inflammation and fibrosis in a lung experimental model of idiopathic pulmonary fibrosis. Life Sci 2021;287:120123. [PMID: 34748761 DOI: 10.1016/j.lfs.2021.120123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wei S, Zhang Z, Yan L, Mo Y, Qiu X, Mi X, Lai K. miR-20a Overexpression in Adipose-Derived Mesenchymal Stem Cells Promotes Therapeutic Efficacy in Murine Lupus Nephritis by Regulating Autophagy. Stem Cells Int 2021;2021:3746335. [PMID: 34721589 DOI: 10.1155/2021/3746335] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Yang C, Sun J, Tian Y, Li H, Zhang L, Yang J, Wang J, Zhang J, Yan S, Xu D. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus. Front Immunol 2021;12:714832. [PMID: 34603289 DOI: 10.3389/fimmu.2021.714832] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
11 Lv X, Wang L, Zou X, Huang S. Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges. Drug Des Devel Ther 2021;15:3927-36. [PMID: 34584402 DOI: 10.2147/DDDT.S323107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Matheakakis A, Batsali A, Papadaki HA, Pontikoglou CG. Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications. Int J Mol Sci 2021;22:10132. [PMID: 34576296 DOI: 10.3390/ijms221810132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang FS. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther 2021;6:339. [PMID: 34497264 DOI: 10.1038/s41392-021-00754-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yang Q, Liu Y, Chen G, Zhang W, Tang S, Zhou T. An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus. Stem Cells Int 2021;2021:2168595. [PMID: 34434237 DOI: 10.1155/2021/2168595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chaichian Y, Wallace DJ. Innovative Trials and New Opportunities in SLE. Rheum Dis Clin North Am 2021;47:481-99. [PMID: 34215375 DOI: 10.1016/j.rdc.2021.04.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wong SC, Medrano LC, Hoftman AD, Jones OY, McCurdy DK. Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series. Pediatr Rheumatol Online J 2021;19:87. [PMID: 34112214 DOI: 10.1186/s12969-021-00575-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Liu Y, Su YY, Yang Q, Zhou T. Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis. Stem Cell Res Ther 2021;12:333. [PMID: 34112221 DOI: 10.1186/s13287-021-02391-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 Lwin SM, Snowden JA, Griffiths CEM. The promise and challenges of cell therapy for psoriasis. Br J Dermatol 2021. [PMID: 34036569 DOI: 10.1111/bjd.20517] [Reference Citation Analysis]
19 Wei Z, Yuan J, Wang G, Ocansey DKW, Xu Z, Mao F. Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases. Stem Cells Int 2021;2021:5583994. [PMID: 33859701 DOI: 10.1155/2021/5583994] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 El-Jawhari JJ, El-Sherbiny Y, McGonagle D, Jones E. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors? Front Immunol 2021;12:643170. [PMID: 33732263 DOI: 10.3389/fimmu.2021.643170] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
21 Yang C, Wu M, You M, Chen Y, Luo M, Chen Q. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther 2021;12:103. [PMID: 33541422 DOI: 10.1186/s13287-021-02158-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
22 Yuan C, Li R, Liu G, Pan Y. Potential of Immune-Related Therapy in COVID-19. Front Pharmacol 2020;11:609212. [PMID: 33574756 DOI: 10.3389/fphar.2020.609212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lin S, Lin W, Liao C, Zhou T. Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants. Stem Cells Int 2020;2020:8819757. [PMID: 33424979 DOI: 10.1155/2020/8819757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lee HK, Kim HS, Pyo M, Park EJ, Jang S, Jun HW, Lee TY, Kim KS, Bae SC, Kim Y, Hong JT, Yun J, Han SB. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas lpr mice. Theranostics 2020;10:10186-99. [PMID: 32929342 DOI: 10.7150/thno.46835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]